Tysabri FDA Approval Under Special Distribution Program For ...

Medical News Today - UK
The FDA has approved the resumption of Tysabri (natalizumab), a drug for patients with a relapsing form of multiple sclerosis, under a special restricted ...
See all stories on this topic

MultiVu Video Feed: The Food and Drug Administration Approves the ...
Yahoo! News (press release) - USA
... of a supplemental Biologics License Application (sBLA) by the US Food and Drug Administration (FDA) for the reintroduction of TYSABRI® (natalizumab) as a ...

Green light for drug brings hope to Elan;Special report
Therapeutics Daily (subscription) (press release) - Newtown,PA,USA
Approval for new blockbuster Tysabri will seal revival of Irish pharma group. By Paul Durman. IN a shabby hotel in a scruffy suburb ...

US stocks tumble as Bernanke warns on inflation
Moneycontrol.com - Mumbai,India
... The Biotech Index fell 3.6 percent after the US Food and Drug Administration paved the way for multiple sclerosis drug Tysabri to go back on the market, but ...

Small Town And Big Time
Blogcritics.org - Aurora,OH,USA
... reintroduced. Tysabri was cleared for a market return, although high financial market returns aren't expected until much later. ...

US stocks sink as Bernanke warns on inflation
Ninemsn - Sydney,New South Wales,Australia
... The Biotech Index (.BTK) fell 3.6 percent to 645.20 after the US Food and Drug Administration paved the way for multiple sclerosis drug Tysabri to go back on ...